Heart valve risk with some Parkinson's drugs may be greater than believed, two studies show
Copyright 2007 Associated Press All Rights Reserved Associated Press Worldstream January 03, 2007 By MARILYNN MARCHIONE, AP Medical Writer MILWAUKEE
Best wishes,
Copyright 2007 Associated Press All Rights Reserved Associated Press Worldstream January 03, 2007 By MARILYNN MARCHIONE, AP Medical Writer MILWAUKEE
Text of a warning lewtter sent to physicians: http://www.fda.gov/medwatch/SAFETY/2003/permax.htm"The risk of heart valve damage with two drugs for Parkinson's disease may be far greater than was known, new research suggests.
"One of the Parkinson's drugs, pergolide, sold as Permax and other brands, also is used to treat restless legs syndrome. Cabergoline, sold as Dostinex, Cabaser, and other names, is mostly used in Europe.
"Moderate to severe valve problems were seen in 23 percent of those on pergolide and nearly 29 percent of those on cabergoline, but none of those on other Parkinson's drugs, and less than 6 percent of the comparison group.
"Cabergoline is approved in the U.S. for treating a hormone problem, excessive prolactin in the blood, but not Parkinson's."
Best wishes,